Talk to Robyn

00 1 718 213 49 04

Search inside this page

All regions

Free Market Research Guides to Download

Drug Discovery and Development Analysis & Statistics, January 2013 (p20)

You might be interested in: clinical trial, drug discovery, drug development, more »

» Purchase Premium Reports

571-610 of about 2 900 reports

Armenia Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Armenia

Congo Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Congo, Democratic Republic Of

Burkina Faso Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Burkina Faso

Botswana Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Botswana

Afghanistan Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Afghanistan

Bangladesh Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Bangladesh

Number Of Approvals Of Registration-drug_clinical Trials Of Imported Drug-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug Discovery and Development

Australia Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2011
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Australia

Argentina Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Argentina

Number Of Approvals Of Registration-drug_imported Drug Registration-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug Discovery and Development
Drug Discovery and Development in China: 3SBio Inc. ? Product Pipeline Review - H2 2011

Drug Discovery and Development in China: 3SBio Inc. ? Product Pipeline Review - H2 2011

  • $ 1 500
  • Company report
  • August 2012
  • by Global Markets Direct

- Product Pipeline Review - H2 2011? provides a detailed overview on the 3SBio Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Angioedema Global Clinical Trials Review, H2, 2012

Angioedema Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Angioedema Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Angioedema Global Clinical Trials Review, H2, 2012" provides data on the Angioedema clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World
World Drug Discovery and Development: NOXXON Pharma AG - Product Pipeline Review - H2 2011

World Drug Discovery and Development: NOXXON Pharma AG - Product Pipeline Review - H2 2011

  • $ 1 500
  • Company report
  • August 2012
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Drug Discovery and Development
  • Countries : World
Drug Discovery and Development Industry: Biovista Inc. ? Product Pipeline Review - Q1 2011

Drug Discovery and Development Industry: Biovista Inc. ? Product Pipeline Review - Q1 2011

  • $ 1 500
  • Company report
  • August 2012
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Dysmenorrhea - Pipeline Review, H2 2012

Dysmenorrhea - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Dysmenorrhea - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Dysmenorrhea - Pipeline Review, H2 2012', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides ...

  • Industries : Drug Discovery and Development
  • Countries : China, World
World Pharmaceutical: EpiCept Corporation - Product Pipeline Review - H2 2011

World Pharmaceutical: EpiCept Corporation - Product Pipeline Review - H2 2011

  • $ 1 500
  • Company report
  • August 2012
  • by Global Markets Direct

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Initiating Rare Disease Drug Discovery Projects

Initiating Rare Disease Drug Discovery Projects

  • $ 2 875
  • Industry report
  • August 2012
  • by SCRIP Insights

In comparison with major diseases, the targeting of rare diseases poses many different challenges, necessitating consideration of bespoke R&D strategies for drug discovery efforts to be successful. This ...

  • Industries : Drug Discovery and Development
Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012" provides data on the ...

  • Industries : Drug Discovery and Development
  • Countries : World
Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2012" provides data on ...

  • Industries : Drug Discovery and Development
  • Countries : World
Osteoporosis Global Clinical Trials Review, H2, 2012

Osteoporosis Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Osteoporosis Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Osteoporosis Global Clinical Trials Review, H2, 2012" provides data on the Osteoporosis clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Cerebral Hypoxia Global Clinical Trials Review, H2, 2012

Cerebral Hypoxia Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Cerebral Hypoxia Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Cerebral Hypoxia Global Clinical Trials Review, H2, 2012" provides data on the Cerebral Hypoxia ...

  • Industries : Drug Discovery and Development
  • Countries : World
Amblyopia Global Clinical Trials Review, H2, 2012

Amblyopia Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Amblyopia Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Amblyopia Global Clinical Trials Review, H2, 2012" provides data on the Amblyopia clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World
Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2012

Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Dilated Cardiomyopathy Global Clinical Trials Review, H2, 2012" provides data on the Dilated ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Biliary Cirrhosis Global Clinical Trials Review, H2, 2012

Biliary Cirrhosis Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Biliary Cirrhosis Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Biliary Cirrhosis Global Clinical Trials Review, H2, 2012" provides data on the Biliary Cirrhosis ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Rhinosinusitis Global Clinical Trials Review, H2, 2012

Rhinosinusitis Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Rhinosinusitis Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Rhinosinusitis Global Clinical Trials Review, H2, 2012" provides data on the Rhinosinusitis clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Accutest Research Laboratories (I) Pvt. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Accutest Research Laboratories (I) Pvt. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

Accutest Research Laboratories (I) Pvt. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Accutest Research Laboratories (I) Pvt. Ltd. (Accutest) is a contract research organization, ...

  • Industries : Drug Discovery and Development
  • Countries : India
Aptiv Solutions - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aptiv Solutions - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

Aptiv Solutions - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Aptiv Solutions is a pharmaceutical and healthcare company that operates as a contract research organization and provides ...

  • Industries : Drug Discovery and Development
eClinical Solutions Market - [CTMS, CDMS, EDC, IVRS, ePRO & IRB Systems] Global Trends, Opportunities & Forecasts (2012 - 2017)

eClinical Solutions Market - [CTMS, CDMS, EDC, IVRS, ePRO & IRB Systems] Global Trends, Opportunities & Forecasts (2012 - 2017)

  • $ 4 650
  • Industry report
  • August 2012
  • by MarketsandMarkets

eClinical solutions are employed to manage the entire process of a clinical trial as well as the large amounts of data involved at various stages and from various sites. They help in efficient and accurate ...

  • Industries : Drug Discovery and Development
  • Countries : World
Strategies for Comparative Efficacy Trials

Strategies for Comparative Efficacy Trials

  • $ 3 800
  • Industry report
  • August 2012
  • by Datamonitor

Clinicians and patients want to be able to compare new drugs with those already available to inform evidence-based medicine, and reimbursement authorities require comparative data to support their decisions. ...

  • Industries : Drug Discovery and Development
  • Countries : United States, United Kingdom, Germany
Partnership Models and Emerging Destinations for R&D Outsourcing

Partnership Models and Emerging Destinations for R&D Outsourcing

  • $ 3 800
  • Industry report
  • August 2012
  • by Datamonitor

As outsourcing penetration has increased, pharma companies increasingly compete on how efficiently they interact with CROs. Strategic partnerships arose, in part, as a way to reduce the burden of oversight ...

  • Industries : Drug Discovery and Development
  • Countries : China, India, World, Czech Republic, South Korea, Brazil, Qatar, Jordan, Egypt, Asia, Europe, Argentina, Ukraine, Russian Federation, Poland, Bulgaria, Thailand, Taiwan, South America
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

  • $ 3 500
  • Industry report
  • August 2012
  • by GBI Research

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research ...

  • Industries : Drug Discovery and Development
  • Countries : India, China, World
Drug Discovery and Development: CytoCore, Inc. (CYOE)

Drug Discovery and Development: CytoCore, Inc. (CYOE)

  • $ 750
  • Company report
  • August 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the CytoCore, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Global Array Instruments Market (Life Science And BioTechnology Instruments) - Global Industry Share, Size Growth And Forecast, 2011 - 2017

Global Array Instruments Market (Life Science And BioTechnology Instruments) - Global Industry Share, Size Growth And Forecast, 2011 - 2017

  • $ 2 395
  • Industry report
  • August 2012
  • by Transparency Market Research

Description This report is an effort to identify factors, which will be the driving force behind the array market and sub-markets in the next few years. The report provides extensive analysis of the industry, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Fungemia Global Clinical Trials Review, H2, 2012

Fungemia Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Fungemia Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Fungemia Global Clinical Trials Review, H2, 2012" provides data on the Fungemia clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World
Narcolepsy Global Clinical Trials Review, H2, 2012

Narcolepsy Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Narcolepsy Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Narcolepsy Global Clinical Trials Review, H2, 2012" provides data on the Narcolepsy clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World
Leprosy Global Clinical Trials Review, H2, 2012

Leprosy Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Leprosy Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Leprosy Global Clinical Trials Review, H2, 2012" provides data on the Leprosy clinical trial scenario. This ...

  • Industries : Drug Discovery and Development
  • Countries : World
Duodenal Ulcer Global Clinical Trials Review, H2, 2012

Duodenal Ulcer Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Duodenal Ulcer Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Duodenal Ulcer Global Clinical Trials Review, H2, 2012" provides data on the Duodenal Ulcer clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World
Septic Shock Global Clinical Trials Review, H2, 2012

Septic Shock Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Septic Shock Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Septic Shock Global Clinical Trials Review, H2, 2012" provides data on the Septic Shock clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Gaucher%s Disease Global Clinical Trials Review, H2, 2012

Gaucher%s Disease Global Clinical Trials Review, H2, 2012

  • $ 2 500
  • Industry report
  • August 2012
  • by Global Data

Gaucher's Disease Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, ?Gaucher's Disease Global Clinical Trials Review, H2, 2012" provides data on the Gaucher's Disease ...

  • Industries : Drug Discovery and Development
  • Countries : World
Japan Pharma Review: Outlook to 2017

Japan Pharma Review: Outlook to 2017

  • $ 3 800
  • Industry report
  • August 2012
  • by Datamonitor

Japan's pharmaceutical industry is in the midst of a defining period. The sector has evolved dramatically over the past decade, as companies attempt to gain ground on their Western peers in meeting the ...

  • Industries : Drug Discovery and Development
  • Countries : Japan

» Read our Company Profiles

About 100 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.